Dimenhydrinate
Sponsors
St. Justine's Hospital, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Prince of Songkla University, Apsen Farmaceutica S.A., Pamukkale University
Conditions
GastroenteritisGynecologic NeoplasmHealthy WomenNauseaPerioperative OptimizationPostoperative Nausea and VomitingVertigoVertigo, Peripheral
Phase 2
Phase 3
Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin
CompletedNCT02112578
Start: 2016-11-01End: 2017-12-01Updated: 2023-02-08
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
CompletedNCT04606264
Start: 2023-05-15End: 2025-03-21Updated: 2025-10-17
Phase 4
A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis
CompletedNCT00124787
Start: 2005-04-30End: 2012-02-29Updated: 2012-03-01
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
CompletedNCT02253524
Start: 2012-11-30End: 2013-05-31Updated: 2014-10-01
Unknown Phase
Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting
CompletedNCT00791960
Start: 2008-11-30End: 2009-09-30Updated: 2010-03-29
The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy: Randomized-controlled Trial
Not yet recruitingNCT06395064
Start: 2024-05-01End: 2026-04-30Target: 160Updated: 2024-05-01